Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
Authors
Keywords
ALS, Aberrant glial cells, Neurodegeneration, Masitinib, M-CSF
Journal
Journal of Neuroinflammation
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-05
DOI
10.1186/s12974-016-0620-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves
- (2016) Anna Martínez-Muriana et al. Scientific Reports
- Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats
- (2016) Masamichi Okubo et al. PLoS One
- Stimulation of Monocytes, Macrophages, and Microglia by Amphotericin B and Macrophage Colony-Stimulating Factor Promotes Remyelination
- (2015) A. Doring et al. JOURNAL OF NEUROSCIENCE
- Injured sensory neuron–derived CSF1 induces microglial proliferation and DAP12-dependent pain
- (2015) Zhonghui Guan et al. NATURE NEUROSCIENCE
- Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling
- (2015) Fabiola Rojas et al. Frontiers in Cellular Neuroscience
- Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
- (2014) G. M. Thomsen et al. JOURNAL OF NEUROSCIENCE
- Neuroprotective effect of masitinib in rats with postischemic stroke
- (2014) Ivan Kocic et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
- (2013) Rachna S. Pandya et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
- (2013) Weihua Zhao et al. Journal of Neuroimmune Pharmacology
- M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia
- (2013) Amy M Smith et al. Journal of Neuroinflammation
- Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS
- (2013) Emiliano Trias et al. Frontiers in Cellular Neuroscience
- Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1 G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis
- (2012) Jae Chul Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
- (2012) Patrick Vermersch et al. BMC Neurology
- Microglia and mast cells: two tracks on the road to neuroinflammation
- (2012) Stephen D. Skaper et al. FASEB JOURNAL
- Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
- (2012) Oleg Butovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase
- (2012) Jean-Nicolas Audet et al. PLoS One
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis
- (2011) P. Diaz-Amarilla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
- (2011) François Piette et al. Alzheimers Research & Therapy
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase
- (2009) Genevieve Gowing et al. EXPERIMENTAL NEUROLOGY
- Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
- (2009) Hristelina Ilieva et al. JOURNAL OF CELL BIOLOGY
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
- (2009) I. M. Chiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase
- (2008) G. Gowing et al. JOURNAL OF NEUROSCIENCE
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
- (2008) Koji Yamanaka et al. NATURE NEUROSCIENCE
- CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
- (2008) D. R. Beers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started